Skip to main content
. 2020 Sep 12;20(6):571–590. doi: 10.1007/s40256-020-00439-5

Fig. 2.

Fig. 2

Pooled mortality estimate (OR) associated with the use of ACEIs/ARBs. Heterogeneity: I2 = 74%; p = 0.001. ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, CI confidence interval, OR odds ratio